Measles vaccine efficacy during an epidemic in 1998 in the highly vaccinated population of Poland

Vaccine

Volumn 21, Issue 5-6, 2003, Pages 473-478

  Janaszek, Wieslawa ^a   Gay, Nigel J ^b   Gut, Wlodzimierz ^a  

^a NATIONAL INSTITUTE OF HYGIENE   (Poland)

^b Immunisation Division   (United Kingdom)

Author keywords

Efficacy; Measles; Vaccine

Indexed keywords

MEASLES VACCINE;

ARTICLE; DRUG EFFICACY; EPIDEMIC; HUMAN; MEASLES; MEASLES VACCINATION; POPULATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE FACTORS; ALGORITHMS; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HUMANS; INFANT; MALE; MEASLES; MEASLES VACCINE; POLAND; VACCINATION;

EID: 0037449510     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00482-6     Document Type: Article

References (11)

1. Janaszek W., Gut W., Gay N.J. The epidemiology of measles in Poland: prevalence of measles virus antibodies in the population. Epidemiol. Infect. 125:2000;385-392.
2. de Quadros C.A., Olive J.M., Hersh B.S.et al. Measles elimination in the Americas, evolving strategies. JAMA. 275:1996;224-229.
3. Carson M.M., Spady D.W., Albrecht P.et al. Measles vaccination of infants in a well-vaccinated population. Pediatr. Infect. Dis. J. 14:1995;17-22.
4. Maldonato Y.A., Lawrance E.C., de Hovitz R., Hartzell H., Albrecht P. Early loss of passive measles antibody in infants of mothers with vaccine induced immunity. Pediatrics. 96:1995;447-450.
5. de Serres G., Joly J.R., Fauvel M., Meyer F., Mâsse B., Boulianne N. Passive immunity against measles during the first 8 months of life of infants born to vaccinated mothers or to mothers who sustained measles. Vaccine. 15:1997;620-623.
6. Ward B.J., Boulianne N., Ratnam S., Guiot M.C., Couillard M., de Serres G. Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination. J. Infect. Dis. 172:1995;1591-1595.
7. Watson J.C., Pearson J.A., Markowitz L.E.et al. An evaluation of measles revaccination among school-entry-aged children. Pediatrics. 97:1996;613-618.
8. Poland G.A., Jacobson R.M., Thampy A.M.et al. Measles reimmunization in children seronegative after initial immunization. JAMA. 277:1997;1156-1158.
9. De Serres G., Sciberras J., Naus M., Boulianne N., Duval B., Rochette L. Protection after two doses of measles vaccine is independent of interval between doses. J. Infect. Dis. 180:1999;187-190.
10. Vitek C.R., Aduddell M., Brinton M.J., Hoffman R.E., Redd S.C. Increased protections during a measles outbreak of children previously vaccinated with a second dose of measles-mumps-rubella vaccine. Prediatr. Infect. Dis. J. 18:1999;620-623.
11. Ramsay M. Strategic plan for the elimination of measles in the European Region. WHO Expanded Programme on Immunization. Seventh Meeting of National Programme Managers. Berlin, Germany, November 1997.